Indirubin-3′-oxime is primarily investigated for its potential therapeutic applications, particularly in the field of cancer research. It has shown promise as an inhibitor of cyclin-dependent kinases (CDKs), which are crucial regulators of cell cycle progression. By targeting these kinases, it may help in arresting the growth of cancer cells, making it a candidate for anticancer drug development. Additionally, it has been studied for its anti-inflammatory properties, offering potential benefits in treating inflammatory diseases. Research also explores its role in neurodegenerative disorders due to its ability to modulate cellular pathways involved in cell survival and death. Overall, Indirubin-3′-oxime holds significant interest in medicinal chemistry for its diverse biological activities.